Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.

Jiajun Wang,Shuli Chou,Zhanyi Yang,Yang,Zhihua Wang,Jing Song,Xiujing Dou,Anshan Shan
DOI: https://doi.org/10.1021/acs.jmedchem.7b01729
IF: 8.039
2018-01-01
Journal of Medicinal Chemistry
Abstract:Antimicrobial peptides are an important weapon against invading pathogens and are potential candidates as novel antibacterial agents, but their antifungal activities are not fully developed. In this study, a set of imperfectly amphipathic peptides was developed based on the imperfectly amphipathic palindromic structure R n(XRXXXRX)R n ( n = 1, 2; X represents L, I, F, or W), and the engineered peptides exhibited high antimicrobial activities against all fungi and bacteria tested (including fluconazole-resistant Candida albicans), with geometric mean (GM) MICs ranging from 2.2 to 6.62 μM. Of such peptides, 13 (I6) (RRIRIIIRIRR-NH2) that was Ile rich in its hydrophobic face had the highest antifungal activity (GMfungi = 1.64 μM) while showing low toxicity and high salt and serum tolerance. It also had dramatic LPS-neutralizing propensity and a potent membrane-disruptive mechanism against microbial cells. In summary, these findings were useful for short AMPs design to combat the growing threat of drug-resistant fungal and bacterial infections.
What problem does this paper attempt to address?